SGYP
Synergy Pharmaceuticals, Inc Common Stock
SGYP
SGYP
Delisted
SGYP was delisted on the 7th of March, 2019.
89 hedge funds and large institutions have $4.12M invested in Synergy Pharmaceuticals, Inc Common Stock in 2018 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 16 increasing their positions, 39 reducing their positions, and 57 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
97% less capital invested
Capital invested by funds: $164M → $4.12M (-$160M)
Holders
89
Holding in Top 10
–
Calls
$141K
Puts
$239K
Top Buyers
| 1 | +$174K | |
| 2 | +$57.7K | |
| 3 | +$54.5K | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$30.2K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$29.7K |
Top Sellers
| 1 | -$14M | |
| 2 | -$4.25M | |
| 3 | -$2.38M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.15M |
| 5 |
NC
Nexthera Capital
New York
|
-$1.27M |